The latest report on ‘ Meningococcal Vaccine market’ as added by Market Study Report offers comprehensive details on industry size, regional spectrum and revenue estimates of the business. In addition, the report stresses on major challenges as well as the latest growth strategies implemented by significant players of the industry.

Global Meningococcal Vaccine Market Size to reach USD 4.38 Billion by 2027.

Global Meningococcal Vaccine Market was valued at USD 2.11 Billion in 2019 and expected to grow with a CAGR 9.5% over the forecast period 2020-2027.

Meningococcal Vaccine is used in Invasive meningococcal disease. Invasive meningococcal disease (IMD) is a bacterial virus with a variety of diseases involving meningitis, bacteremia (meningococcemia), and bacteremia pneumonia affected by a gram-negative coccus, Neisseria meningitidis.  The meningococcal disease is rare, if left unchecked, it is associated with a high mortality risk of up to 50% and commonly leads to severe complications afterwards. The disease is usually spread by patients or asymptomatic carriers via close contact with droplets of respiratory or throat secretions. N. (Neisseria)Various serotypes of N. Meningitidis are found in 12 serogroups, of which only 5 serogroups are responsible for  most of diseases worldwide, including A, B, C, W, and Y. Surge in immunization programs across the globe and increase in outbreaks of meningococcal disease drive the market globally.

Request a sample Report of Meningococcal Vaccine Market at:

Key features of Meningococcal Vaccine market report:

Growth rate

World market overview

Detailed market segmentation

Industry drivers

Impact of COVID-19 on the market

Regional bifurcation

Market concentration rate analysis

New products and potential entrants

Granular analysis on major manufacturers

Key challenges

Revenue forecasts

Mergers, acquisitions, and expansion

Regional Analysis of Meningococcal Vaccine market:

Meningococcal Vaccine Market Segmentation:

Americas (United States, Canada, Mexico, Brazil)

APAC (China, Japan, Korea, Southeast Asia, India, Australia)

Europe (Germany, France, UK, Italy, Russia)

Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

Overview of the regional terrain of Meningococcal Vaccine market:

Detailed insights with country-wise analysis.

Market share accounted by each region.

Consumption rates of each region.

Revenue forecast of each terrain.

Expected growth rate during the analysis timeframe.

Key economic indicators.

Meningococcal Vaccine market Segmented into:

By Vaccine Serotype:


MenB & Manic




By Vaccine Type:




By End Users:




Details stated in the report:

Consumption rates of all applications listed.

Market share of each application fragment.

Product sale price of every application segment.

Other details specified in the report:

The report assesses the challenges that may hinder the market expansion.

The report also incorporates the ongoing market trends.

Major distributors and customers are also included while structuring the report.

Competitive landscape of Meningococcal Vaccine market:


Bio-Med Pvt. Limited

Chongqing Zhifei Biological Products Co., Ltd.

GlaxoSmithKline Plc

Hualan Biological Engineering Inc.

Incepta Pharmaceuticals Ltd.

Pfizer Inc.

Sanofi S.A

Serum institute of India Pvt. Ltd

Walvax Biotechnology Co., Ltd

Major features as per the report:

Detailed profiling of every company listed in the report.

Products offered by major companies.

Valuable insights such as sales, revenue, product price, and gross margin.

Business overview of each company listed.

Recent developments in the company.

Major area of sales and the competitors present in the area.

Key features of this report are:

The report delivers the market valuation as well as the projected growth rate of the global Meningococcal Vaccine market spanning all years till 2027.

The report also describes the major drivers of worldwide Meningococcal Vaccine market by considering as well as taking calculated risks, in tandem with identifying and testing new strategies.

The research report endorses a detailed industry chain analysis. Also, it covers the production process of Meningococcal Vaccine, upstream raw material supplier information, raw material costs, labor costs, manufacturing costs, marketing channels, as well as the downstream buyers of the Meningococcal Vaccine market.

The report provides detailed knowledge about the competitive scenario of the global Meningococcal Vaccine market, and also discusses the numerous marketing strategies adopted by companies to stay ahead in the competition.

The report analyses the various market segments and also provides their contribution to the development of the global Meningococcal Vaccine market.

The key questions answered in the report:        

What will be the market size and growth rate in the forecast year?

What are the key factors driving the Global Meningococcal Vaccine Market?

What are the risks and challenges in front of the market?

Who are the key vendors in the Global Meningococcal Vaccine Market?

What are the trending factors influencing the market shares?

What are the key outcomes of Porter’s five forces model?

Which are the global opportunities for expanding the Global Meningococcal Vaccine Market?

For More Details On this Report:

About Us:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report. is the platform that can help you in achieving any of these objectives.

Contact Us:

Corporate Sales,

Market Study Report

Phone: 1-302-273-0910

Toll Free: 1-866-764-2150


Leave a comment

Your email address will not be published. Required fields are marked *